tiprankstipranks
Zimmer Biomet price target raised to $130 from $120 at Canaccord
The Fly

Zimmer Biomet price target raised to $130 from $120 at Canaccord

Canaccord analyst Kyle Rose raised the firm’s price target on Zimmer Biomet to $130 from $120 and keeps a Buy rating on the shares. The analyst noted they put up a solid Q4 in spite of continued macro headwinds, with OUS materially outperforming given lighter comps and procedure recovery.

Published first on TheFly

See today’s best-performing stocks on TipRanks >>

Read More on ZBH:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles